A phase I trial of LBS-007 in patients with hematologic cancers

Trial Profile

A phase I trial of LBS-007 in patients with hematologic cancers

Planning
Phase of Trial: Phase I

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs LBS 007 (Primary)
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic myeloid leukaemia; Haematological malignancies; Myelodysplastic syndromes
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 08 Mar 2017 New trial record
    • 03 Mar 2017 According to a Lin Bioscience media release, this trial is expected to initiate in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top